P. Lang, J. Proust, T. Vogel, and R. Aspinall, Saurons-nous jamais ce qui provoque le vieillissement ? NPG Neurologie -Psychiatrie -Gériatrie, pp.337-380, 2013.
DOI : 10.1016/j.npg.2013.03.008

J. Rowe and R. Kahn, The future of aging, Contemp Longterm Care

L. Merle, M. Laroche, T. Dantoine, and J. Charmes, Predicting and Preventing Adverse Drug Reactions in the Very Old, Drugs & Aging, vol.21, issue.3, pp.375-92, 2005.
DOI : 10.2165/00002512-200522050-00003

URL : https://hal.archives-ouvertes.fr/hal-01335822

F. Péhourcq and M. Molimard, Pharmacocin??tique chez le sujet ??g??, Revue des Maladies Respiratoires, vol.21, issue.5, pp.25-32, 2004.
DOI : 10.1016/S0761-8425(04)71559-4

S. Ferchichi and V. Antoine, Le bon usage des médicaments chez la personne âgée. La Revue de Médecine Interne, pp.582-90, 2004.
DOI : 10.1016/j.revmed.2004.02.027

C. Lafuente-lafuente, É. Baudry, E. Paillaud, and F. Piette, Pharmacologie clinique et vieillissement, La Presse M??dicale, vol.42, issue.2, pp.171-80
DOI : 10.1016/j.lpm.2012.06.023

M. Bauer, R. Karch, F. Neumann, A. Abrahim, C. Wagner et al., Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET, European Journal of Clinical Pharmacology, vol.23, issue.9
DOI : 10.1007/s00228-009-0709-5

A. Kaye, A. Baluch, and J. Scott, Pain Management in the Elderly Population: A Review

J. Ochsner, HAS. Evaluation du débit de filtration glomérulaire et du dosage de la créatininémie dans le diagnostic de la maladie rénale de l'adulte, pp.179-87, 2010.

P. Tonner, J. Kampen, and J. Scholz, Pathophysiological changes in the elderly, Best Practice & Research Clinical Anaesthesiology, vol.17, issue.2
DOI : 10.1016/S1521-6896(03)00010-7

J. Piccirillo, A. Vlahiotis, L. Barrett, K. Flood, E. Spitznagel et al., The changing prevalence of comorbidity across the age spectrum, Critical Reviews in Oncology/Hematology, vol.67, issue.2
DOI : 10.1016/j.critrevonc.2008.01.013

P. Grosclaude, V. Quipourt, L. Mouret, and L. Remontet, Etat des lieux et perspectives en oncogériatrie Données épidémiologiques sur les cancers du sujet âgé. 2009 p. 68. 33?87. 16. HAS. Comment améliorer la qualité et la sécurité des prescriptions de médicaments chez la personne âgée? http

L. Auvray and C. Sermet, Consommations et prescriptions pharmaceutiques chez les personnes âgées. Gérontologie et société, pp.13-27, 2002.
DOI : 10.3917/gs.103.0013

URL : http://www.cairn.info/load_pdf.php?ID_ARTICLE=GS_103_0013

P. Carbonin, M. Pahor, R. Bernabei, and A. Sgadari, Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc, 1991.

I. Les-cancers-en-france, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou et al., Cancer incidence and mortality in France over the period 1980?2005. Revue d'Épidémiologie et de Santé Publique, pp.159-75, 2008.

H. Merskey, B. Nrigattieri, S. Guerin, and J. , Classification of chronic pain Descriptions of chronic pain syndromes and definitions of pain terms Force on taxonomy of international association for the study of pain ANAES. Evaluation et suivi de la douleur chronique chez l'adulte en médecine ambulatoire. 1999. 23. HAS. Douleur chronique : reconnaître le syndrome douloureux chronique, l'évaluer et orienter le patient http, Douleurs cancéreuses : bonnes pratiques cliniques de prise en charge, gestions des opioïdes forts. La Presse Médicale, pp.252-62, 1994.

M. Kleef and J. Patijn, Prevalence of pain in patients with cancer: a systematic review of the past 40 years, Ann Oncol, vol.18, issue.9, pp.1437-1486, 2007.

I. Breivik, H. Cherny, N. Collett, B. De-conno, F. Filbet et al., Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes, Annals of Oncology, vol.20, issue.8, pp.1420-1453, 2009.
DOI : 10.1093/annonc/mdp001

E. Collin, B. Fergane, I. Krakowski, and E. Pichard-leandri, Stratégie d'évaluation et de traitement d'un malade souffrant de douleur cancéreuse, pp.199-242, 2004.

I. Krakowski, G. Sor, and . Standards, Options et Recommandations 2002 pour les traitements antalgiques médicamenteux des douleurs cancéreuses par excès de nociception chez l'adulte, mise à jour (rapport abrégé) Bulletin du Cancer, pp.1067-74, 2003.

T. Meuser, C. Pietruck, L. Radbruch, P. Stute, K. Lehmann et al., Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology, Pain, vol.93, issue.3, pp.247-57, 2001.
DOI : 10.1016/S0304-3959(01)00324-4

T. Delorme, W. C. Standards-botting, R. Ayoub, and S. , Options et Recommandations pour l'évaluation de la douleur chez l'adulte et l'enfant atteints d'un cancer (mise à jour) COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins, Leukotrienes and Essential Fatty Acids, pp.85-92, 2003.

T. Pelissier, A. Alloui, C. Paeile, and A. Eschalier, Evidence of a central antinociceptive effect of paracetamol involving spinal 5HT3 receptors, NeuroReport, vol.6, issue.11, pp.1546-1554, 1995.
DOI : 10.1097/00001756-199507310-00020

V. Martinez, N. Attal, D. Bouhassira, and M. Lantéri-minet, Les douleurs neuropathiques chroniques??: diagnostic, ??valuation et traitement en m??decine ambulatoire. Recommandations pour la pratique clinique de la Soci??t?? fran??aise d?????tude et de traitement de la douleur, Douleurs : Evaluation - Diagnostic - Traitement, vol.11, issue.1
DOI : 10.1016/j.douler.2009.12.009

D. Fletcher, Pharmacologie des opioïdes. EMC -Anesthésie-Réanimation, 2011.

W. Leppert, Tramadol as an analgesic for mild to moderate cancer pain, Pharmacological Reports, vol.61, issue.6, pp.978-92, 2009.
DOI : 10.1016/S1734-1140(09)70159-8

P. Wiffen, B. Wee, R. Moore, I. Krakowski, and M. J. , Oral morphine for cancer pain Douleurs cancéreuses par excès de nociception chez l'adulte : mise au point sur les recommandations concernant les traitements antalgiques médicamenteux. Annales Françaises d'Anesthésie et de Réanimation, Cochrane Database Syst Rev, vol.726, issue.6, pp.502-517, 2007.

C. Quigley, Opioid switching to improve pain relief and drug tolerability, Cochrane Database Syst Rev, issue.3, p.4847, 2004.

J. Pergolizzi, R. Böger, K. Budd, A. Dahan, S. Erdine et al., Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone), Pain Practice, vol.47, issue.suppl 2
DOI : 10.1111/j.1533-2500.2008.00204.x

N. Cherny, C. Ripamonti, J. Pereira, C. Davis, M. Fallon et al., Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report, Journal of Clinical Oncology, vol.19, issue.9, 2001.
DOI : 10.1200/JCO.2001.19.9.2542

P. Glare, D. Walsh, and D. Sheehan, The Adverse Effects of Morphine: A Prospective Survey of Common Symptoms During Repeated Dosing for Chronic Cancer Pain, American Journal of Hospice and Palliative Medicine, vol.23, issue.3, pp.229-264, 2006.
DOI : 10.1177/1049909106289068

S. Mercadante, G. Porzio, P. Ferrera, F. Fulfaro, F. Aielli et al., Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management, European Journal of Pain, vol.7, issue.Suppl. A, pp.1040-1046, 2008.
DOI : 10.1016/j.ejpain.2008.01.013

Z. Zuo, The Role of Opioid Receptor Internalization and ??-Arrestins in the Development of Opioid Tolerance, Anesthesia & Analgesia, vol.101, issue.3, pp.728-762, 2005.
DOI : 10.1213/01.ANE.0000160588.32007.AD

H. Ueda, Locus-Specific Involvement of Anti-Opioid Systems in Morphine Tolerance and Dependence, Annals of the New York Academy of Sciences, vol.23, issue.1, pp.376-82, 2004.
DOI : 10.1196/annals.1307.046

S. Mitra and R. Sinatra, Perioperative Management of Acute Pain in the Opioid-dependent Patient, Anesthesiology, vol.101, issue.1, pp.212-239, 2004.
DOI : 10.1097/00000542-200407000-00032

R. Vallejo, O. De-leon-casasola, and R. Benyamin, Opioid Therapy and Immunosuppression, American Journal of Therapeutics, vol.11, issue.5, pp.354-65, 2004.
DOI : 10.1097/01.mjt.0000132250.95650.85

. Régionaux-de-pharmacovigilance, Serious " adverse drug reactions with tramadol: a 2010- 2011 pharmacovigilance survey in France, Therapie. 2013, vol.68, issue.2, pp.77-84

L. Hutchins, J. Unger, J. Crowley, C. Coltman, and K. Albain, Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials, New England Journal of Medicine, vol.341, issue.27, pp.2061-2068, 1999.
DOI : 10.1056/NEJM199912303412706

D. Urban, N. Cherny, and R. Catane, The management of cancer pain in the elderly, Critical Reviews in Oncology/Hematology, vol.73, issue.2
DOI : 10.1016/j.critrevonc.2009.03.008

K. Auret and S. Schug, Underutilisation of Opioids in Elderly Patients with Chronic Pain, Drugs & Aging, vol.59, issue.2, pp.641-54, 2005.
DOI : 10.2165/00002512-200522080-00002

D. Lussier and P. Beaulieu, Toward a rational taxonomy of analgesic drugs, pp.27-40, 2010.

M. Beers, Explicit criteria for determining potentially inappropriate medication use by the elderly. An update, Archives of Internal Medicine, vol.157, issue.14, pp.1531-1537, 1997.
DOI : 10.1001/archinte.157.14.1531

M. Laroche, F. Bouthier, M. L. Charmes, and J. , M??dicaments potentiellement inappropri??s aux personnes ??g??es??: int??r??t d???une liste adapt??e ?? la pratique m??dicale fran??aise, La Revue de M??decine Interne, vol.30, issue.7
DOI : 10.1016/j.revmed.2008.08.010

M. Andro, S. Estivin, and A. Gentric, Prescriptions m??dicamenteuses en g??riatrie??: overuse (sur-utilisation), misuse (mauvaise utilisation), underuse (sous-utilisation). Analyse qualitative ?? partir des ordonnances de 200??patients entrant dans un service de court s??jour g??riatrique, La Revue de M??decine Interne, vol.33, issue.3, pp.122-129, 2012.
DOI : 10.1016/j.revmed.2011.11.016